<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>clinicaltrialdesign on Kaspar Rufibach</title>
    <link>https://numbersman77.netlify.com/tags/clinicaltrialdesign/</link>
    <description>Recent content in clinicaltrialdesign on Kaspar Rufibach</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <copyright>&amp;copy; 2019</copyright>
    <lastBuildDate>Thu, 13 Aug 2020 00:00:00 +0000</lastBuildDate>
    
	<atom:link href="https://numbersman77.netlify.com/tags/clinicaltrialdesign/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>github respository for different analysis methods for principal stratum estimands motivated by the principal ignorability assumption</title>
      <link>https://numbersman77.netlify.com/software/principalstratification/</link>
      <pubDate>Thu, 13 Aug 2020 00:00:00 +0000</pubDate>
      
      <guid>https://numbersman77.netlify.com/software/principalstratification/</guid>
      <description>Bj√∂rn Bornkamp, Kaspar Rufibach, Jianchang Lin, Yi Liu, Devan Mehrotra, Satrajit Roychoudhury, Heinz Schmidli, Yue Shentu, Marcel Wolbers (2020): Principal Stratum Strategy: Potential Role in Drug Development</description>
    </item>
    
    <item>
      <title>github respository for MIRROS clinical trial design</title>
      <link>https://numbersman77.netlify.com/software/mirros/</link>
      <pubDate>Wed, 28 Aug 2019 00:00:00 +0000</pubDate>
      
      <guid>https://numbersman77.netlify.com/software/mirros/</guid>
      <description>Kaspar Rufibach, Dominik Heinzmann, Annabelle Monnet (2019): Integrating Phase 2 into Phase 3 based on an Intermediate Endpoint While Accounting for a Cure Proportion - with an Application to the Design of a Clinical Trial in Acute Myeloid Leukemia</description>
    </item>
    
  </channel>
</rss>